Chronic leukemia: an overview

Published on October 31, 2024   39 min

A selection of talks on Haematology

Please wait while the transcript is being prepared...
0:00
Hello. I'm Dr Seema Ali Bhat. I am an Associate Professor in the division of Hematology, Department of Internal Medicine at the Ohio State University. I'll be talking about "Chronic Lymphocytic Leukemia" today.
0:17
In this talk, we will go over diagnostic criteria, staging and risk stratification, rationale for observation in asymptomatic patients, treatment indications in symptomatic patients, approach to selecting initial treatment, regimens and their complications, and areas of ongoing research.
0:41
Chronic lymphocytic leukemia is the most prevalent adult leukemia in the United States. This is a disease of older patients with median age at diagnosis of around 72 years. There's slight male predominance and is more common in whites. This disease is fairly rare in the Asian population. Annually there are about 4,500 deaths due to chronic lymphocytic leukemia. However over the last two decades, there has been an increase in the overall survival of patients with chronic lymphocytic leukemia. This is due to improved therapies that are available currently as well as due to an increase in the length time bias that we see nowadays due to the patients getting routine blood work done which detects CLL at an early stage.
1:33
By definition, chronic lymphocytic leukemia is a clonal B-cell malignancy. There's accumulation of immunologically incompetent mature appearing lymphocytes in the blood, bone marrow, lymph nodes, and spleen. By definition, there has to be presence of 5,000 or more clonal B-cells in the blood. These have to be persistent for more than three months and clonality is confirmed by light chain restriction either Kappa or Lambda light chain restriction. By immunophenotype, these cells express B- cell antigens, for example, CD19, CD20, and CD23. They also express B-cell antigen CD5, which is unique. There is low to dim surface immunoglobulin expression as well as CD20 expression and CD79 B expression. On smear, you will see small mature appearing lymphocytes and you will also see smudge cells which are characteristic of CLL. There are various diseases that could be in

Quiz available with full talk access. Request Free Trial or Login.